|

歐元/美元:疫苗擔憂回歸,歐元將轉跌

歐元/美元:疫苗擔憂回歸,歐元將轉跌

FXStreet分析師Yohay Elam發布報告稱,歐元兌美元因樂觀的疫苗和增長預期而反彈,但有關歐元區免疫供應的擔憂以及美聯儲的鷹派立場可能會改變這種前景。

歐元兌美元或反彈過頭了

“根據最新估計,甚至在夏季之前,這是大多數歐洲人可能接種新冠疫苗的時間。歐盟的樂觀疫苗預期以及國際貨幣基金組織(imf)上調經濟預測。國際貨幣基金組織將全球經濟增長預期上調至6%,其中也包括歐元區國家。 ”

“疫苗擔憂再次浮出水面。 Moderna告訴德國,它將被迫推遲下一批疫苗的裝運——延長了所有藥品推遲裝運的趨勢。此外,歐盟的免疫計劃嚴重依賴阿斯利康的疫苗接種,而且不太可能所有歐洲人都接受。歐洲藥品管理局(EMA)將提供一份關於其與血凝塊潛在相關性的最新報告。 ”

“美聯儲將公佈最新的3月會議紀要,可能會顯示樂觀情緒上升。投資者可能會將這一樂觀信號解讀為一種微妙的暗示,即藉貸成本將很快上升,而不是推遲上升,從而提振美元。 ”

“阻力位於日高1.1880,然後為1.1920,該位曾在3月中旬提供支撐。支持位於1.1820,該位曾阻擋匯價上漲,然後為1.1780。 ”

作者

FXStreet Team

Composed of a group of economic journalists and FX experts, the FXStreet content team produces and oversees all content published on FXStreet. It provides a purely journalistic approach to the Forex market.

更多來自 FXStreet Team
分享:

編輯精選

AUD/USD sits at fresh 10-month lows, nears 0.6700

AUD/USD refreshes ten-month lows below 0.6750 and approaches 0.6700 in Wednesday’s Asian session. Fed rate-hike bets, along with fresh exchange of fire between the US and Iran, underpin the safe-haven US Dollar. Furthermore, the RBA’s dovish tilt weighs on the Aussie and the pair.

USD/JPY defends bids near 159.50 on hawkish BoJ Ueda

USD/JPY is defending bids near 159.50 in the Asian session on Wednesday, holding a three-day losing streak after hawkish commentary from BoJ Governor Ueda supports the Japanese Yen amid looming intervention risks. Meanwhile, escalating Middle East tensions revive US Dollar demand amid hawkish Fed bets, which could limit the pair's downside.



Gold tumbles to its lowest in over a year as Fed rate hike bets build

Gold (XAU/USD) falls below $3,800 on Wednesday, hitting its lowest level since September 2025 as traders increasingly expect the Federal Reserve (Fed) to keep interest rates higher for longer.

Bitcoin stalls as ETF outflows mount ahead of Fed Minutes

Bitcoin stalls near $65,000 on Wednesday as buyers struggle to sustain a recovery from last week’s decline toward $62,000. Weakening institutional demand so far this week from BTC spot Exchange Traded Funds continues to weigh on sentiment.

Nvidia offers up double beat in third quarter

Nvidia (NVDA) shares jumped 3% afterhours as the leading AI chipmaker easily surpassed Wall Street's projections for the third quarter. The semiconductor powerhouse posted adjusted earnings per share of $2.68, 8.5% or $0.21 better than the consensus. Revenue of $115.85 billion clobbered the consensus by $7.1 billion or 6.6%.

Gold isn't being sold for the reason most people think
Gold (XAU/USD) remains under heavy selling pressure on Monday, hitting its lowest level in 13 months. The precious metal is struggling to recover despite escalating geopolitical tensions in the Middle East, a backdrop that would normally encourage investors to seek protection in safe-haven assets. However, the main driver behind Gold's decline is not the geopolitical uncertainty itself.